COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil
A recent article in Biospace reported an 83% survival rate for COVID-19 patients after two infusions of the experimental drug Ryoncil, developed by Mesoblast Ltd. The patients who were…